Shatavari originated in Ayurveda, the traditional system of Indian medicine, and is native to India and the Himalayan region. Its history is first documented in foundational Ayurvedic scriptures such as the Charaka Samhita and the Sushruta Samhita. In Sanskrit, “Shatavari” translates to “she who possesses a hundred husbands,” symbolizing its association with femininity and reproductive prosperity. Ancient Sanskrit texts recommend Shatavari supplementation to support menstruation, boost fertility, and increase break milk production in nursing mothers. These texts also detail its long-standing use in enhancing longevity and vitality.
Today, Shatavari continues to evolve within modern medicinal practices as herbalists and researchers explore its safety and efficacy for traditional and integrative applications. Historical documentation and recent findings illustrate Shatavari’s potential to make a meaningful impact for women’s health.
Research in female reproductive health highlights the historic underrepresentation of women in the scientific sphere. As inclusion in clinical studies expands for female reproductive and hormonal health, interest in herbal alternatives to pharmaceutical interventions has also increased. Shatavari represents a growing component of the knowledge base surrounding women’s health, particularly regarding menopausal and hormonal irregularities. The following five studies provide compelling evidence for the positive effect of Shatavari in premenopausal, perimenopausal, and postmenopausal women.
The first study employed an eight-week, double-blind design to evaluate the efficacy and safety of Shatavari root extract (SHT) alone and in combination with Ashwagandha root extract (ARE) in women experiencing menopausal symptoms. The 135 participants, women aged 45-65 years old, were divided evenly among three groups: SHT, ARE-SHT, and a control group. The effects of the herbal interventions were measured using the Menopause Rating Scale (MRS) and the Menopause-Specific Quality of Life Questionnaire (MENQOL). Researchers observed significant improvement in MRS scores in the SHT and ARE-SHT groups, although the ARE-SHT group demonstrated especially notable effects. Additionally, MENQOL reports improved, suggesting enhanced mood and self-esteem-related outcomes. The study illustrated the safe and promising effects of Shatavari root extract in menopausal women and suggested the potential for additional overall health benefits when combined with Ashwagandha root extract.
The second study reviewed existing research regarding the hormonal effects, reproductive benefits, and stress-modulating properties of Shatavari root. Supplements were administered in various forms, including capsules, powders, and tinctures. The review summarized studies reporting significant relief from menopausal symptoms, improved reproductive outcomes in women with irregular cycles and hormonal disorders, increased lactation in postpartum women, and reduced oxidative stress. This article refined current findings and called for the integration of traditional Ayurvedic knowledge with contemporary scientific research, advancing upon our understanding of female reproductive health, hormonal regulation, and management of conditions such as Premenstrual Syndrome (PMS), Polycystic Ovary System (PCOS), and menopause.
The third article investigated the effects of dietary supplementation with Shatavari and Ashwagandha extracts, examining their individual and combined influence on menopausal symptoms, vascular dysfunction, bone turnover, and inflammatory and oxidative stress markers in postmenopausal women. The study enrolled women aged 40-55 years old in a double-blind trial in which participants received one of six treatment combinations: placebo, two different doses of Shatavari extract, two different doses of Ashwagandha extract, or a combination of both supplements. Results were measured after 24 weeks using MENQOL scores, bone mineral density and bone turnover markers (BTMs), and Reflection Index (RI). Additional measurements included inflammatory and oxidative stress markers and evaluations of supplement safety and tolerability. Researchers found that all supplemented groups demonstrated significant, dose-dependent decreases in MENQOL and RI compared with the placebo group. Additionally, the supplemented groups showed significantly reduced bone turnover and resorption. Inflammatory and oxidative stress markers also decreased, correlating with reduced estrogen deficiency-related inflammation in postmenopausal women. These findings suggest that daily supplementation with Shatavari or Ashwagandha extracts may reduce menopausal symptoms and vascular dysfunction while improving overall health.
The fourth study evaluated the safety and efficacy of CL22205, a standardized Shatavari root extract, in managing perimenopausal symptoms in 50 women experiencing mild to moderate climacteric symptoms. Participants received either 200 mg/day of Shatavari extract or a placebo over 120 consecutive days. Measured outcomes included the Menopausal Rating Scale (MRS), Hot Flash Weekly Weighted Score (HFWWS), Menstrual Symptom Questionnaire (MSQ), Integrative Medicine Patient Satisfaction and Outcome Scales (IMPSS & IMOS), and other general measures of reproductive and hormonal health. Participants reported significantly reduced MRS scores and HFWWS scores compared with both placebo and baseline measurements following the treatment period. Menstrual symptoms and other health measures also showed significant improvement, with no reported adverse effects. This study concluded that Shatavari may effectively reduce vasomotor symptoms, menstrual discomfort, and hormonal imbalances, while also improving skin and hair health. Shatavari supplementation therefore demonstrates potential as a safe and natural alternative for perimenopausal symptom management.
The fifth study reviewed findings on stress-mediated reproductive health disorders in women and the potential role of Shatavari as a treatment option. Research indicated that Shatavari may help hormonal imbalance due to its phytoestrogenic properties, regulating estrous or ovarian cycles while reducing menopausal symptoms. One study reported Shatavari’s potential to alleviate PMS, dysmenorrhoea, and pituitary gland dysfunctions while promoting growth, differentiation, and physiological functions of the female gential tract. One study demonstrated that supplementation with 10mg of Shatavari per day reduced symptoms associated with polycystic ovarian syndrome, a common reproductive health condition often linked to infertility. This review summarized recent findings supporting that Shatavari may benefit female fertility, nourish the ovaries, and enhance the body’s antioxidant capacity to help correct reproductive health disorders.
